293 related articles for article (PubMed ID: 11568763)
1. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
Aguilar C; Mueller KK
J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
[TBL] [Abstract][Full Text] [Related]
2. [Terbinafine (Lamisil)].
Breton MC
Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
[No Abstract] [Full Text] [Related]
3. Toenails and agranulocytosis.
Pillans PI; Boyd IW
Intern Med J; 2007 Aug; 37(8):572-5. PubMed ID: 17640191
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole and terbinafine in perspective. From petri dish to patient.
De Doncker P; Gupta AK
Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
[TBL] [Abstract][Full Text] [Related]
6. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
Ornstein DL; Ely P
J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
[No Abstract] [Full Text] [Related]
7. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
Kikuchi I; Tanuma H; Morimoto K; Kawana S
Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
[TBL] [Abstract][Full Text] [Related]
8. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
[TBL] [Abstract][Full Text] [Related]
10. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
Van Duyn Graham L; Elewski BE
Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
[TBL] [Abstract][Full Text] [Related]
11. Neutropenia and pancytopenia associated with oral terbinafine.
Kovacs MJ; Alshammari S; Guenther L; Bourcier M
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
[No Abstract] [Full Text] [Related]
12. Management of onychomycosis in children.
Gupta AK; De Rosso JQ
Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
[TBL] [Abstract][Full Text] [Related]
13. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
Schäfer-Korting M; Schoellmann C; Korting HC
Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
[TBL] [Abstract][Full Text] [Related]
14. Terbinafine: an oral and topical antifungal agent.
Shear NH; Villars VV; Marsolais C
Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
[No Abstract] [Full Text] [Related]
15. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
Gupta AK; Lynch LE; Kogan N; Cooper EA
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
[TBL] [Abstract][Full Text] [Related]
16. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
17. Onychomycosis treated with a short course of oral terbinafine.
Galimberti R; Kowalczuk A; Flores V; Squiquera L
Int J Dermatol; 1996 May; 35(5):374-5. PubMed ID: 8734666
[No Abstract] [Full Text] [Related]
18. Topical butenafine for tinea pedis.
Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
[No Abstract] [Full Text] [Related]
19. Thrombocytopenia associated with oral terbinafine.
Grunwald MH
Int J Dermatol; 1998 Aug; 37(8):634. PubMed ID: 9732018
[No Abstract] [Full Text] [Related]
20. Terbinafine: agranulocytosis.
Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17590912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
